The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The impact of switching systemic treatment after radiosurgery (SBRT) for oligo-progressive, metastatic renal cell carcinoma (mRCC).
 
Pedro C. Barata
No Relationships to Disclose
 
Rupesh Kotecha
No Relationships to Disclose
 
Prateek Mendiratta
No Relationships to Disclose
 
Aditya Juloori
No Relationships to Disclose
 
Lilyana Angelov
No Relationships to Disclose
 
Samuel T. Chao
No Relationships to Disclose
 
Paul Elson
No Relationships to Disclose
 
Vadim S. Koshkin
No Relationships to Disclose
 
Moshe Chaim Ornstein
No Relationships to Disclose
 
Timothy D. Gilligan
Travel, Accommodations, Expenses - WellPoint
 
Petros Grivas
Consulting or Advisory Role - AstraZeneca; Bayer; Biocept; Bristol-Myers Squibb; Clovis Oncology; Dendreon; EMD Serono; Exelixis; Genentech; Merck
Speakers' Bureau - Bristol-Myers Squibb; Genentech
Research Funding - AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst); Pfizer (Inst)
 
Laura S. Wood
Consulting or Advisory Role - Exelixis; Merck
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Exelixis; Novartis; Pfizer
 
Brian I. Rini
Consulting or Advisory Role - Corvus Pharmaceuticals; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Jorge A. Garcia
Consulting or Advisory Role - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation; Pfizer; Sanofi
Speakers' Bureau - Bayer; Genentech/Roche; Medivation/Astellas; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Lilly (Inst); Orion (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation/Astellas; Pfizer; Sanofi